Novartis AG vs Charles Schwab Corporation Common Stock — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while Charles Schwab Corporation Common Stock trades at $107.87 (market cap $186.25B). The key difference: Novartis AG is the larger of the two by market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| NVS | SCHW | |
|---|---|---|
Market Cap | $295.37B | $186.25B |
Sector | Health | Financials |
52-Week High | $168.62 | $108.02 |
52-Week Low | $119.31 | $85.35 |
Enterprise Value | $336.69B | — |
Dividend Yield | 3.07% | 1.19% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →